Details for New Drug Application (NDA): 018257
✉ Email this page to a colleague
The generic ingredient in TONOCARD is tocainide hydrochloride. There is one drug master file entry for this compound. Additional details are available on the tocainide hydrochloride profile page.
Summary for 018257
Tradename: | TONOCARD |
Applicant: | Astrazeneca |
Ingredient: | tocainide hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 018257
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 400MG | ||||
Approval Date: | Nov 9, 1984 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 600MG | ||||
Approval Date: | Nov 9, 1984 | TE: | RLD: | No |
Expired US Patents for NDA 018257
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Astrazeneca | TONOCARD | tocainide hydrochloride | TABLET;ORAL | 018257-002 | Nov 9, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
Astrazeneca | TONOCARD | tocainide hydrochloride | TABLET;ORAL | 018257-001 | Nov 9, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
Astrazeneca | TONOCARD | tocainide hydrochloride | TABLET;ORAL | 018257-002 | Nov 9, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription